The Impact of COVID-19 is included in In-Silico Drug Discovery Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
In-Silico Drug Discovery Trends and Forecast
The future of the global in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets. The global in-silico drug discovery market is expected to reach an estimated $5.45 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
In-Silico Drug Discovery by Segment
The study includes a forecast for the global in-silico drug discovery by type, target therapeutic area, workflow, end use, and region.
In-Silico Drug Discovery Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Software as a Service
• Consultancy as a Service
• Software
In-Silico Drug Discovery Market by Target Therapeutic Area [Shipment Analysis by Value from 2018 to 2030]:
• Human Immunodeficiency Virus (HIV)
• Infectious Diseases
• Metabolic Disorders
• Mental Disorders
• Musculoskeletal Disorders
• Neurological Disorders
• Oncological Disorders
• Respiratory Disorders
• Others
In-Silico Drug Discovery Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:
• Discovery
• Target Identification
• Reverse Docking
• Bioinformatics
• Protein Structure Prediction
• Target Validation
• Lead Discovery
• Pharmacophore
• Others
In-Silico Drug Discovery Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Contract Research Organizations
• Pharmaceutical Industry
• Academic & Research Institutes
• Others
In-Silico Drug Discovery Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of In-Silico Drug Discovery Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies in-silico drug discovery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-silico drug discovery companies profiled in this report include-
• Curia
• Certara
• Charles River Laboratories
• Chemical Computing
• GenScript
• Sygnature Discovery
• Abzena
In-Silico Drug Discovery Market Insights
Lucintel forecasts that software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.
Within this market, pharmaceutical industry will remain the largest segment due as in-silico drug discovery helps the pharmaceutical companies to reduce the time and cost of developing new drugs.
North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of marlet players, and large patient population suffering from various chronic and infectious diseases in the region.
Features of the Global In-Silico Drug Discovery Market
Market Size Estimates: In-silico drug discovery market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: In-silico drug discovery market size by various segments, such as by type, target therapeutic area, workflow, end use, and region in terms of value ($B).
Regional Analysis: In-silico drug discovery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, target therapeutic areas, workflow, end uses, and regions for the in-silico drug discovery market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the in-silico drug discovery market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the in-silico drug discovery market size?
Answer: The global in-silico drug discovery market is expected to reach an estimated $5.45 billion by 2030.
Q2. What is the growth forecast for in-silico drug discovery market?
Answer: The global in-silico drug discovery market is expected to grow with a CAGR of 10.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the in-silico drug discovery market?
Answer: The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.
Q4. What are the major segments for in-silico drug discovery market?
Answer: The future of the in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets.
Q5. Who are the key in-silico drug discovery market companies?
Answer: Some of the key in-silico drug discovery companies are as follows:
• Curia
• Certara
• Charles River Laboratories
• Chemical Computing
• GenScript
• Sygnature Discovery
• Abzena
Q6. Which in-silico drug discovery market segment will be the largest in future?
Answer: Lucintel forecasts that software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.
Q7. In in-silico drug discovery market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of marlet players, and large patient population suffering from various chronic and infectious diseases in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the in-silico drug discovery market by type (software as a service, consultancy as a service, and software), target therapeutic area (human immunodeficiency virus (HIV), infectious diseases, metabolic disorders, mental disorders, musculoskeletal disorders, neurological disorders, oncological disorders, respiratory disorders, and others), workflow (discovery, target identification, reverse docking, bioinformatics, protein structure prediction, target validation, lead discovery, pharmacophore, and others), end use (contract research organizations, pharmaceutical industry, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to In-Silico Drug Discovery Market, In-Silico Drug Discovery Market Size, In-Silico Drug Discovery Market Growth, In-Silico Drug Discovery Market Analysis, In-Silico Drug Discovery Market Report, In-Silico Drug Discovery Market Share, In-Silico Drug Discovery Market Trends, In-Silico Drug Discovery Market Forecast, In-Silico Drug Discovery Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global In-Silico Drug Discovery Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global In-Silico Drug Discovery Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global In-Silico Drug Discovery Market by Type
3.3.1: Software as a service
3.3.2: Consultancy as a service
3.3.3: Software
3.4: Global In-Silico Drug Discovery Market by Target Therapeutic Area
3.4.1: Human Immunodeficiency Virus (HIV)
3.4.2: Infectious diseases
3.4.3: Metabolic disorders
3.4.4: Mental disorders
3.4.5: Musculoskeletal disorders
3.4.6: Neurological disorders
3.4.7: Oncological disorders
3.4.8: Respiratory disorders
3.4.9: Others
3.5: Global In-Silico Drug Discovery Market by Workflow
3.5.1: Discovery
3.5.2: Target identification
3.5.3: Reverse docking
3.5.4: Bioinformatics
3.5.5: Protein structure prediction
3.5.6: Target validation
3.5.7: Lead discovery
3.5.8: Pharmacophore
3.5.9: Others
3.6: Global In-Silico Drug Discovery Market by End Use
3.6.1: Contract research organizations
3.6.2: Pharmaceutical industry
3.6.3: Academic & research institutes
3.6.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global In-Silico Drug Discovery Market by Region
4.2: North American In-Silico Drug Discovery Market
4.2.2: North American In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others
4.3: European In-Silico Drug Discovery Market
4.3.1: European In-Silico Drug Discovery Market by Type: Software as a service, Consultancy as a service, and Software
4.3.2: European In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others
4.4: APAC In-Silico Drug Discovery Market
4.4.1: APAC In-Silico Drug Discovery Market by Type: Software as a service, Consultancy as a service, and Software
4.4.2: APAC In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others
4.5: ROW In-Silico Drug Discovery Market
4.5.1: ROW In-Silico Drug Discovery Market by Type: Software as a service, Consultancy as a service, and Software
4.5.2: ROW In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global In-Silico Drug Discovery Market by Type
6.1.2: Growth Opportunities for the Global In-Silico Drug Discovery Market by Target Therapeutic Area
6.1.3: Growth Opportunities for the Global In-Silico Drug Discovery Market by Workflow
6.1.4: Growth Opportunities for the Global In-Silico Drug Discovery Market by End Use
6.1.5: Growth Opportunities for the Global In-Silico Drug Discovery Market by Region
6.2: Emerging Trends in the Global In-Silico Drug Discovery Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global In-Silico Drug Discovery Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global In-Silico Drug Discovery Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Curia
7.2: Certara
7.3: Charles River Laboratories
7.4: Chemical Computing
7.5: GenScript
7.6: Sygnature Discovery
7.7: Abzena
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - In-Silico Drug Discovery Market Report.